Source: The Scotsman

Synpromics: Major acquisition for Scotland's crucial life sciences sector

Edinburgh-based gene therapy specialist Synpromics has been acquired by a US-based peer in what has been described as a "game changing deal".

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more